News

Last week, on December 29, 2020, the Food and Drug Administration (“FDA”) published a notice setting the amount of new annual facility fees for both for over-the-counter (“OTC”) monograph drug product manufacturers and for OTC monograph drug product contract manufacturing organizations (“CMOs”).

Part 2: New Laws Impacting California Public Agencies for 2021 - Among the new laws passed last year by California were a variety that seek to address the State’s ongoing housing shortage and environmental issues.

In 2020 the legal segment of the marijuana industry exceeded $10 billion dollars in the United States with California alone generating $3.1 billion in sales in 2019, and Colorado in a close second at $1.6 billion.

The interview below is part of an ongoing effort by McGuireWoods to profile key leaders in the dental industry....
By: McGuireWoods LLP

On December 27, 2020, President Trump signed the COVID-19 relief and government funding bill, which incorporated The Trademark Modernization Act of 2020 (“TMA”) and the Copyright Alternative in Small-Claims Enforcement Act of 2020 (“CASE Act”).

Contract with “substantial connection” with NC leads to PJ over a California Defendant who never visited NC. In Toshiba Global Commerce Solutions, Inc. v.

New federal requirements in the annual national defense budget reauthorization effectively will end anonymous U.S. shell companies by requiring businesses to disclose 25 percent owners and control persons to a newly created federal registry maintained by the U.S. Treasury Department.

In this new Bulletin, consultant Protiviti identifies key issues for the 2021 audit committee agenda and—no surprise—at least half reflect the impact of COVID-19.

Pages